First AD

Second AD

Expert Insights on Biomarker Testing in Early-Stage Breast Cancer

Best practices for biomarker testing in early-stage breast cancer

Dr. McCann to ask Dr Hurvitz:What are you typically testing for in early-stage breast cancer? (HR, PR, HER2, others?)

Dr McCann to ask Dr Kaklamani:What testing methodologies are most typically used? How do they differ and what can you learn from each? (NGS, FISH, IHC, panels, etc.)What sample types are best? (tissue vs. liquid)

Dr McCann to ask Dr Pegram:How do results guide treatment?

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Breast Cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

Video Series

Updates in the Treatment of HR+ Breast Cancer  

Peer Exchange

Leading oncologists explore optimal biomarker testing strategies for early-stage breast cancer, examining the comparative advantages of tissue and liquid biopsies to guide personalized treatment decisions.